The hormones ghrelin and leptin act via the lateral hypothalamic area (LHA) to modify energy balance, but the underlying neural mechanisms remain unclear. We investigated how leptin and ghrelin engage LHA neurons to modify energy balance behaviors and whether there is any crosstalk between leptin and ghrelin-responsive circuits. We demonstrate that ghrelin activates LHA neurons expressing hypocretin/orexin (OX) to increase food intake. Leptin mediates anorectic actions via separate neurons expressing the long form of the leptin receptor (LepRb), many of which coexpress the neuropeptide neurotensin (Nts); we refer to these as Nts LepRb A daptive energy balance is the process by which the brain detects changes in energy status and directs appropriate feeding and energy expenditure behaviors to resolve the imbalance. The lateral hypothalamic area (LHA) is crucial for this process, as demonstrated by rodents with LHA lesions that lose motivation to ingest and move, even in the face of starvation (1, 2). Understanding of how the LHA mediates adaptive energy balance, however, has been complicated by the neuronal complexity of this brain region (3). For example, LHA neurons containing the classical neurotransmitters GABA or glutamate modify ingestion, but yet-to-be defined subpopulations appear to control distinct aspects of feeding behavior (4-6). LHA neurons can also be defined by their neuropeptide expression, such as populations that express the neuropeptides melanin-concentrating hormone (MCH) or hypocretin/orexin (OX) and play important roles in arousal and promoting feeding (7-9). The LHA also contains neurons that express the neuropeptide neurotensin (Nts), which are implicated in suppressing feeding behavior in response to dehydrationanorexia (10), inflammation (11), or the anorectic hormone
leptin (12) . Indeed, at least some LHA Nts neurons express the long form of the leptin receptor (LepRb) and are directly activated by leptin: we refer to these as Nts LepRb neurons.
LHA neuronal populations may detect specific energy cues and thus differentially control feeding and locomotor behavior to adapt energy balance. The LHA receives two important hormone regulators of adaptive energy balance: leptin and ghrelin. Leptin is made by adipose cells in proportion to energy stores, is released into the circulation, and binds to LepRb-expressing neurons throughout the brain (13) . Leptin acts specifically via LepRb neurons in the LHA to modify feeding, physical activity, and nutrient reward; loss of leptin action via these neurons promotes weight gain (12, 14) . Cells of the stomach and gastrointestinal tract secrete ghrelin, a hormone that acts via neurons expressing the growth hormone secretagogue receptor (GHSR) to increase food intake (15) . LHA OX neurons express GHSR, are activated by ghrelin, and mediate at least some part of the orexigenic response to this hormone (16) (17) (18) . Because leptin and ghrelin depolarize target neurons in the LHA (12, 19) but promote opposing behaviors, it is tempting to speculate that they act via separate LHA populations. For example, there are leptin-regulated Nts LepRb neurons and ghrelin-regulated OX neurons that each project to the dopamine-rich ventral tegmental area (VTA) (20, 21) and promote dopamine release to the nucleus accumbens (NAc), which can modify feeding and locomotor activity. Furthermore, leptin and ghrelin action via the LHA engages the dopamine signaling system to suppress or promote feeding, respectively (12, 22, 23) . Thus, there may be separate leptin-and ghrelin-mediated LHA circuits to coordinate peripheral need and dopaminemediated behaviors required to restore energy balance. It remains possible, however, that there is also crosstalk between leptin-and ghrelin-mediated neural circuits to coordinate hormonal responses. Indeed, because Nts LepRb neurons project to and inhibit OX neurons (12, 24) , leptin action via Nts LepRb neurons might be able to suppress the ability of OX neurons to respond to ghrelin. Understanding precisely how leptin and ghrelin engage the LHA is crucial to understanding the regulation of adaptive energy balance and whether pharmacological modulation of these circuits might be a useful strategy to modify body weight.
Here we examined the neural mechanisms by which leptin and ghrelin coordinate adaptive energy balance via the LHA. We found that leptin and ghrelin act directly via separate LHA populations: Nts LepRb and OX neurons, respectively. However, because Nts LepRb neurons project to and inhibit OX neurons (12, 24) , we speculated that leptin action via Nts LepRb neurons suppresses OX neurons and their ability to respond to ghrelin. In the face of increased adiposity, this circuit arrangement would simultaneously enable leptin action while suppressing ghrelin-mediated signaling via the LHA, thus favoring weight loss behaviors. Loss of action via Nts LepRb neurons, however, could derange the response to both leptin and ghrelin. We therefore investigated whether loss of leptin signaling via Nts LepRb neurons impairs the Nts LepRb → OX neuronal circuit, and thus prevents adaptive energy responses to both leptin and ghrelin.
Materials and Methods

Animals
All procedures were approved by the Michigan State University and the University of Michigan Institutional Animal Care and Use Committees, in accordance with Association for Assessment and Accreditation of Laboratory Animal Care and National Institutes of Health guidelines. Mice were bred in house, maintained on a 12-hour light/dark cycle with ad libitum access to food and water, unless otherwise noted. Male mice were used in all metabolic studies, and both males and females were used to examine the distribution of LHA neurons.
Nts cre mice (12) (The Jackson Laboratory stock no. 017525) were crossed onto the C57/Bl6 line for seven generations to obtain fully backcrossed animals. To visualize Nts neurons, Nts cre mice were crossed with Rosa26 EGFP-L10a mice (25) , and heterozygotes were studied (referred to as Nts EGFP mice). Mice lacking LepRb expression in Nts neurons [LepRb knocked out (LRKO) mice] were generated similarly to (12) , but here only C57/Bl6 backcrossed animals were used. Briefly, mixedbackground Lepr fl/fl mice were crossed onto the C57/Bl6 background (The Jackson Laboratory stock no. 008327) for seven generations. Next, backcrossed Nts cre mice were bred with backcrossed Lepr fl/fl mice to generate Nts cre/+ ;Lepr fl/+ and Nts +/+ ;Lepr fl/+ mice, which were subsequently intercrossed to obtain Nts cre/+ ;Lepr fl/fl LRKO study animals and Nts +/+ ;Lepr fl/fl littermate controls (controls). Note that all resulting study mice are on the C57/Bl6 background. Male LRKO and control study mice were single housed at 4 weeks of age and studied between 8 and 37 weeks of age. DNA was extracted from tail biopsies of progeny and analyzed via standard polymerase chain reaction (PCR) to identify study animals (Nts cre : common forward, 5 0 ATA GGC TGC TGA ACC AGG AA; cre reverse, 5 0 CCA AAA GAC GGC AAT ATG GT; and WT reverse, 5 0 CAA TCA CAA TCA CAG GTC AAG AA. Rosa26 EGFP-L10a : mutant forward, 5 0 TCT ACA AAT GTG GTA GAT CCA GGC; WT forward, 5 0 GAG GGG AGT GTT GCA ATA CC; and common reverse, 5 0 CAG ATG ACT ACC TAT CCT CCC). Lepr fl/fl mice were genotyped to verify cre-mediated deletion and the absence of germline Lepr excision (mLepR-105, 5 0 TGA ACA GGC TTG AGA ACA TGA ACA C; mLepR-65-A, 5 0 AGA ATG AAA AAG TTG TTT TGG GAC GAT; mLepR-106, 5 0 GGT GTC TGA TTT GAT AGA TGG TCT T). Mice that genotyped with the absence of germline Lepr excision were not used for studies or for breeding purposes and were euthanized. A terminal tail biopsy was collected at the conclusion of each study, and isolated DNA was used to verify genotype.
Reagents
Recombinant mouse leptin was purchased from the National Hormone and Peptide Program (Los Angeles Biomedical Research Institute, Los Angeles, CA), and mice were treated with 5 mg/kg leptin via intraperitoneal (IP) injection; this leptin dose optimally identifies leptin-responsive LepRb neurons throughout the hypothalamus (12, 23) . Recombinant rat ghrelin was purchased from the PolyPeptide Group (Torrance, CA). Mice were treated with either intracerebroventricular [(ICV) 3 mg] or IP (100 mg) ghrelin. In all cases, control injections consisted of equal volumes of vehicle solution. D-amphetamine hydrochloride (Cayman Chemical, Ann Arbor, MI) was administered to assess activation of the dopamine system (4 mg/kg, IP). Antibodies used for these studies are described in Table 1 .
Immunohistochemistry and immunofluorescence
Mice were anesthetized with a lethal dose of IP pentobarbital and transcardially perfused with phosphate-buffered saline followed by 10% neutral buffered formalin (Fisher Scientific, Pittsburgh, PA). Brains were removed, postfixed overnight in 10% formalin and then dehydrated in 30% sucrose before coronal sectioning (30 mm) into four series using a freezing microtome (Leica, Buffalo Grove, IL). A single series of brain sections was analyzed for each immunostaining experiment.
To identify Nts
LepRb neurons in the LHA, Nts EGFP mice were treated with leptin (5 mg/kg, IP, 2 hours) and brains were analyzed for enhanced green fluorescent protein (EGFP; Nts), OX, and phosphorylated-STAT3 (pSTAT3; a specific marker of leptin-activated LepRb neurons) (26) . To identify neurons activated by ghrelin, Nts EGFP mice were treated with ghrelin (100 mg, IP, 4 hours) and brains were analyzed for EGFP (Nts), OX, and cFos (a marker of neuronal depolarization). Leptinand ghrelin-induced neuronal activation in the NAc was assessed in LRKO and control mice treated for 4 hours with IP leptin, ghrelin, or vehicle (as described previously), and brains were analyzed via immunohistochemistry for cFos. Immunostaining was performed as previously described (21) . Briefly, brain sections were exposed to primary antibodies for either cFos [Santa Cruz, goat, 1:500; research resource identifier (RRID): AB_2629503] or pSTAT3 (Cell Signaling, rabbit, 1:500; RRID: AB_331269), followed by species-specific biotinylated antibodies (Jackson ImmunoResearch, 1:100; RRIDs: AB_2340397 and AB_2340593), avidin-biotinylation reaction (Vectastain; Vector Laboratories), and diaminobenzidine detection (Sigma). Other antibodies were subsequently added and visualized via immunofluorescence, using species-specific Alexa-488 conjugated (Jackson ImmunoResearch, 1:200; RRID: AB_2340375) or Alexa-568 conjugated antibodies (LifeTech, 1:200; RRIDs: AB_2534017 and AB_2534104). Antibodies used for immunofluorescence included GFP (Abcam, chicken, 1:2000; RRID: AB_300798), dsRed/Tomato (Clonetech, rabbit, 1:1000; RRID: AB_10013483), Orexin-A (Santa Cruz, goat, 1:1000; RRID: AB_653611), and MCH (Santa Cruz, goat, 1:1000; RRID: AB_2237276). Brains were analyzed using an Olympus BX53 fluorescence microscope outfitted with transmitted light to analyze diaminobenzidinelabeled tissue, as well as fluorescein isothiocyanate and Texas Red cubes. Microscope images were collected using Cell Sens software and a Qi-Click 12 Bit cooled camera; images were analyzed using Photoshop software (Adobe, San Jose, CA). Cell counts were determined from microscope images, and an average of 6 LHA sections were counted from each brain. For counting purposes, the LHA was designated as the area below and lateral to the mammillothalamic tract (mt) and above the fornix. Each cell type was counted individually and only once (i.e., cells expressing Nts only were counted separately from those expressing Nts and pSTAT3). Counts were made in one series of brain sections, but were multiplied by 4 to obtain total number of neurons per mouse. Graphs represent the average number of neurons 6 standard error of the mean (SEM).
Stereotaxic injection for ICV ghrelin treatment and tract tracing
ICV cannulas were placed in LRKO and control mice to deliver ghrelin centrally. Mice were administered presurgical analgesic, then were anesthetized using vaporized isoflurane/O 2 and placed in a stereotaxic frame. After exposing the skull, an indwelling 26-gauge stainless steel cannula with a removable dummy injector (Plastics One, Roanoke, VA) was implanted into the ventricle. Coordinates to the lateral ventricle (from bregma) were anteroposterior, 20.34; mediolateral, 21.0; and (27) . The stylet was removed and replaced by an injector, via which 250 nL of Adenoviral-Synaptophysin-mCherry (Ad-Syn-mCherry graciously provided by Dr. Martin G. Myers Jr, University of Michigan) was injected into the LHA at a rate of 100 nL/min. After 5 minutes, the injector and cannula were removed from the skull, and the incision was closed using VetBond surgical adhesive. Mice were then housed individually for 5 to 7 days to allow for viral-mediated expression of new proteins and their transport before mice were killed and tissue collected. Mice were only included for study if Syn-mCherry-expressing cell bodies were confined to the LHA.
Metabolic profiling
LRKO and control mice were weaned at 4 weeks of age, maintained on standard rodent chow, and single housed at 7 weeks of age. Body composition was measured between 8 and 10 weeks of age using a nuclear magnetic resonance-based analyzer (Minispec L550; Bruker, Billerica, MA). Mice were then placed in PhenoMaster metabolic cages (TSE Systems, Chesterfield, MO), which are home-cage sized cages outfitted with calorimetry sensors and beam-break sensors to detect x-, y-, and z-plane movement. Ambient temperature was maintained at 20 to 23°C throughout analysis and the airflow rate through the chambers was adjusted to maintain an oxygen differential of ;0.3% at resting conditions. VO 2 and VCO 2 levels in each chamber were sampled for 3-minute bouts rotating through each cage and x-, y-, and z-beam breaks were recorded continuously. Mice were acclimated in chambers for 1 day and then measurements were collected for three full 24-hour cycles. Data from the last full 12-hour light and 12-hour dark cycle were used for analysis. Mice were returned to their home cages for 1 week and then were placed in TSE cages containing a running wheel to assess their voluntary movement, including the amount of time spent on the wheel and running speed.
Sucrose preference testing
LRKO and control mice (10 to 16 weeks) were single housed for at least 1 week before two-bottle sucrose preference testing. For baseline testing of water intake, mice were given two water bottles with sipper tubes, which were placed adjacent to the food hopper. The positions of the bottles were swapped each morning to control for any proximity preference for the bottle closest to the food hopper. Next, the content of one of the bottles was replaced with 1% sucrose, such that the mice had constant access to both water and sucrose-containing bottles. In one experiment, mice were treated every 12 hours for 2 days with vehicle, then with leptin (5 mg/kg, IP), and their daily liquid consumption was measured at 8:00 AM by weighing the bottles. In a separate experiment, mice were treated every 12 hours for 2 days with vehicle, followed by ghrelin (100 mg, IP), during which daily liquid consumption was measured at 5:00 PM by weighing the bottles. Data are reported as sucrose preference, which is the percentage of sucrose consumed out of total liquid consumed. Total water consumption during baseline testing days and during preference testing days was also calculated, but no differences in water intake were observed between genotypes.
Operant responding
Single-housed LRKO and control littermates ages 9 to 37 weeks were given 15 sucrose testing pellets (20 mg sucrose tablets; TestDiet, St. Louis, MO) in their home cage the night before beginning daily testing in operant chambers (Med Associates, St. Albans, VT) to prevent neophobia to sucrose rewards. Each session in the operant chambers lasted 1 hour or until mice received a maximum of 50 sucrose rewards. On the first training day, a sucrose pellet was delivered into the magazine every 30 seconds for a maximum of 50 pellets, so that the mice learned where to obtain sucrose. Mice were then food restricted to 85% of their average food intake, during which they trained to nose poke for sucrose pellets on a fixed ratio (FR)-1 schedule and then an FR-5 schedule. The food restriction was used to incentivize mice to learn the nose-poking task, and is commonly used for food-related operant testing. During FR-1, a nose poke in the active port results in delivery of one sucrose pellet to the magazine, followed by a 5-second timeout during which nose poking will not elicit a sucrose reward (to allow the mouse time to eat the pellet). No sucrose pellet is delivered in response to nose poking in the inactive port. The position of the active poke (right or left side of the chamber) was counterbalanced between mice. Mice were trained on FR-1 until they received a minimum of 20 rewards with $75% accuracy (active pokes out of total active and inactive pokes) for 3 consecutive days. Next, the mice were trained for 3 days on an FR-5 schedule (5 active nose pokes required to receive a sucrose reward, with a 5-second time out). Mice were then restored ad libitum food in their home cages throughout progressive ratio (PR) testing. During PR testing, the response ratio was calculated such that the number of responses required to earn a food reward followed the order: 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95, and so on. The final ratio completed is the breakpoint. Mice were tested via PR until they maintained a stable breakpoint for a minimum of 3 days (defined as the point at which the number of earned rewards deviates by no more than one reward). After achieving stable PR, each mouse was treated with IP vehicle, leptin (5 mg/kg) or ghrelin (100 mg) 1 hour before PR testing to assess how these hormones modify motivated responding. Mice received only one hormone per day, but each mouse received all of the treatments over the course of the experiment.
Gene expression
LRKO (n = 10) and control mice (n = 10) were killed and brains were microdissected to obtain the LHA, VTA, and NAc. The microdissection of the LHA is performed such that it is enriched in MCH, OX, and Nts neurons located above the fornix (the perifornical region) and just lateral and below the mt, roughly between bregma 22.18 mm and 21.06 mm (27) . Two of the LHA samples from control mice were excluded from analysis because the dissections were too rostral and were not centered on the perifornical region. The tissue samples were snap frozen on dry ice and stored at 280°C for later processing. RNA was extracted using Trizol (Invitrogen, Carlsbad, CA), and 200-ng samples were converted to complementary DNA using the Superscript First Strand Synthesis System for reverse transcription (RT)-PCR (Invitrogen). Sample complementary DNAs were analyzed in triplicate via quantitative RT-PCR for gene expression using TaqMan reagents and an Applied Biosystems 7500 (Applied Biosystems, Foster City, CA). GAPDH expression was used as an internal control. Relative messenger RNA expression values are calculated by the 2 2ΔΔCt method, with normalization of each sample to the average DCt value from control mice. Two of the LHA samples from LRKO mice were compromised during tissue processing and were not included in the final results. Additionally, there was a pipetting error while preparing one of the control LHA samples for delta-like 1 (Dlk1) RT-PCR; thus, it was excluded from the final analysis.
Amphetamine-induced assessment of striatal activation
To assess activation of the dopamine system, animals were treated with D-amphetamine hydrochloride (4 mg/kg, IP). Mice were perfused 2 hours after treatment, and brains were immunostained for cFos as described previously.
Data analysis
Paired t tests (to compare two groups) or one-way analysis of variance (ANOVA) with Bonferroni posttesting (for comparisons between multiple groups) were calculated using GraphPad Prism (GraphPad Software Inc., San Diego, CA). Error bars depict 6 SEM. Differences were considered significant for P , 0.05.
Results
Neurotensin neurons are a distinct population of LHA neurons and some respond to leptin
As a first step, we examined the distribution of three neuropeptidedefined populations of LHA neurons that have been implicated in regulating energy balance: those containing MCH, OX, or Nts. Because Nts-expressing neurons cannot be visualized using standard immunolabeling techniques, we examined brains from Nts EGFP mice for expression of Nts-EGFP to identify Nts neurons, along with immunofluorescent labeling of MCH and OX neurons [ Fig. 1(A) ]. Although neurons expressing MCH, OX, and Nts are codistributed throughout the LHA, they do not overlap, indicating that they comprise three separate populations of neurons. Neuronal counts [ Fig. 1(B) ] reveal similarly sized MCH and OX neuronal populations within the LHA (MCH, 2596 6 497 neurons; OX, 2779 6 319 neurons; n = 4) but there are three times as many Nts-EGFP-labeled neurons (Nts, 8832 6 494 neurons; n = 4). These data confirm that LHA Nts neurons are a distinct, highly abundant neuronal population within the LHA, with presumably unique contributions to physiology.
The LHA also contains neurons expressing LepRb, some of which coexpress Nts (12) . Given the large number of LHA Nts neurons, we sought to clarify what proportion of them express LepRb and thus can adaptively modify energy balance in response to leptin. We treated Nts EGFP mice with leptin (5 mg/kg, IP, 2 hours) and examined the distribution of Nts-EGFP neurons along with leptin-induced pSTAT3, which identifies neurons containing functional LepRb. We observed that some, but not all, Nts-EGFP neurons contained pSTAT3 [ Fig. 1(C (Fig. 1) . Neurons expressing the Gq-coupled GHSR can be activated by ghrelin, including OX neurons (17) . It remained unclear, however, if leptin and ghrelin act via completely separately or by overlapping populations of LHA neurons (e.g., perhaps leptin and ghrelin regulate both Nts and OX neurons). To examine this, we first treated Nts EGFP mice with either vehicle or leptin (5 mg/kg, IP, 4 hours) and examined whether Nts and OX neurons exhibit leptin-induced pSTAT3. Leptin treatment significantly increased the percentage of Nts-EGFP neurons containing nuclear pSTAT3 [ Fig. 2(A) , filled arrows, and 2(B): vehicle = 1.2 6 0.6%, n = 4; leptin = 16.1 6 1.5%, n = 5; P , 0.0001], confirming that Nts LepRb neurons respond to leptin. By contrast, very few OX neurons exhibited nuclear pSTAT3 with vehicle treatment; this percentage did not increase in response to leptin [ Fig. 2(A) , unfilled arrows, and 2(B): vehicle = 0.5 6 0.3%, n = 4, leptin = 0.9 6 0.3%, n = 5]. Next, we treated Nts EGFP mice with either vehicle or ghrelin (100 mg, IP, 4 hours) and examined whether Nts and OX neurons exhibit cFos, a marker of neuronal depolarization that has been used to identify ghrelinactivated neurons in rodents and primates (16, 17, 29) . Ghrelin treatment did not increase the percentage of Nts-EGFP neurons that coexpress cFos compared with vehicle treatment, suggesting that ghrelin does not activate Nts neurons [ Fig. 2(C) , unfilled arrows, and 2(D): vehicle = 2.1 6 0.5%, n = 4, ghrelin = 2.9 6 0.3%, n = 4]. Ghrelin treatment did, however, significantly increase the percentage of OX neurons that contain nuclear cFos [ Fig. 2(C) , filled arrows, and 2(D): vehicle = 9.2 6 3.2%, n = 4; ghrelin = 25.3 6 4.3%, n = 4; P = 0.005], consistent with previous reports that OX neurons are directly regulated by ghrelin. Together these data demonstrate that leptin specifically activates Nts LepRb neurons, whereas ghrelin specifically activates OX neurons, and thus that these hormones modify energy balance via separate LHA neuronal populations.
Generation of mice to study the contribution of Nts LepRb neurons to homeostasis and motivated behavior Leptin action via LepRb is crucial for normal regulation of body weight (30) (31) (32) , thus the subset of Nts neurons that respond to leptin, the Nts LepRb neurons, likely contributes to energy balance. Because Nts LepRb neurons are specific to, and confined within, the LHA (12), they may control unique aspects of leptin action compared with non-Ntsexpressing LepRb neurons in other parts of the brain. Indeed, we previously examined the contribution of Nts LepRb neurons in mixed-background LRKO mice); these LRKO mice exhibit mild hyperphagia at young ages, decreased physical activity, and blunted activation of the mesolimbic dopamine system that collectively cause increased body weight (12) . These data suggested that loss of leptin action specifically via Nts LepRb neurons might disrupt both homeostatic and dopamine-mediated motivated behaviors that affect energy balance, such as palatable feeding and nonobligate locomotor activity (22, (33) (34) (35) . Such motivated behaviors must be assessed in pure-background mice to detect meaningful differences; indeed, we could not detect differences in palatable feeding or nonobligate activity in mixed-background LRKO mice (data not shown). Thus, to investigate the contribution of Nts LepRb neurons to motivated behavior and energy balance, we backcrossed control and LRKO mice onto to the C67/Bl6 background, which is the most commonly used genetic background for assessment of motivated behaviors [ Fig. 3(A) ]. As a first step, we verified that backcrossed LRKO mice lack functional LepRb in Nts LepRb neurons by visualizing vehicle and leptin-induced pSTAT3 immunoreactivity in backcrossed control and LRKO mice (5 mg/kg leptin, IP, 2 hours). Vehicle-treated control and LRKO mice had essentially no pSTAT3 within the LHA [ Fig. 3(B) ]. Leptin treatment robustly induced pSTAT3 in the LHA of control mice, but much less so in the LHA of LRKO mice, confirming the loss of functional LepRb in Nts LepRb neurons [ Fig. 3(B) ]. LRKO mice do, however, exhibit some pSTAT3-positive neurons within the LHA, indicating that the non-Nts-containing LHA LepRb neurons are intact. Loss of LepRb is specific to the LHA, the site of Nts LepRb neurons, as demonstrated by the finding that leptin-induces similar amounts of pSTAT3 within other brain regions of control and LRKO mice, such as the arcuate nucleus [ Fig. 3(B) , insets]. These data confirm that backcrossed LRKO mice, like the previously generated mixed-background line (12) Fig. 3(C) , arrows, and 3(D): LRKO mice, vehicle = 44.5 6 1.8%, n = 3; ghrelin = 44.1 6 2.4%, n = 3). It is possible that the loss of inhibitory input from Nts LepRb neurons leads to biased excitatory input onto OX neurons, such that they are at a maximal threshold of activation and cannot be further activated by other signals (such as ghrelin). Differences in ghrelin-mediated activation in control and LRKO mice are not due to altered numbers of OX neurons, because control and LRKO mice have equivalently sized populations of OX neurons [ Fig. 3(E) : control = 1002 6 24 neurons, n = 11; LRKO = 985 6 23 neurons, n = 6, P = 0.928]. Thus, although leptin and ghrelin act via separate populations of LHA neurons, loss of leptin sensing via Nts LepRb neurons that project to OX neurons impairs the ability of OX neurons to be activated by ghrelin. These data suggest that loss of leptin signaling via Nts
treatment [
LepRb neurons may disrupt adaptive energy balance in response to both anorectic and orexigenic cues of energy balance.
Loss of action via Nts
LepRb neurons disrupts energy balance to cause weight gain Leptin and ghrelin are important for modifying homeostatic and motivated behaviors that affect energy balance (22, (33) (34) (35) . Because our data suggest that LRKO mice have blunted leptin-and ghrelin-mediated regulation of LHA neurons, we reasoned that their regulation of body weight is disrupted from altered homeostatic and motivated behaviors. To test this, we compared control and LRKO mice in a battery of metabolic and behavioral tests. Given the lack of increased caloric intake or altered usage, we examined whether the increased body weight of LRKO mice could be due to altered energy expenditure. Indeed, LRKO mice have significantly reduced spontaneous locomotor activity compared with control mice [ Fig. 4(E) : control = 91,341 6 6505 activity counts, LRKO = 70,330 6 4669 activity counts, P = 0.016] and exhibit a trend toward reduced spontaneous oxygen consumption/VO 2 [ Fig. 4(F) : control = 3488 6 118 mL/h/kg, LRKO = 3283 6 133 mL/h/kg, P = 0.257]. These data suggest that deficits in energy expenditure promote weight gain in LRKO mice, and are consistent with data from mixed-background mice (12) . Spontaneous locomotor activity contributes to the regulation of body weight (37), but we reasoned that deficits in motivated, nonvolitional locomotor activity might also contribute to disrupted energy expenditure. Motivated locomotor activity can be assessed in rodents by giving them access to a running wheel, and wheel running promotes activation of mesolimbic dopamine neurons and dopamine release into the striatum (38, 39). We therefore gave control and LRKO mice access to running wheels to determine if loss of leptin signaling through Nts neurons alters nonobligatory (volitional) locomotion. Indeed, LRKO mice spent significantly less time on running wheels than did control mice 
LepRb neurons disrupts adaptive feeding and preference for palatable food In addition to locomotor activity, the mesolimbic dopamine system also modifies the motivation to eat.
Because loss of leptin action via Nts
LepRb neurons disrupts the mesolimbic dopamine system (12) and motivated locomotor activity (Fig. 4) , we reasoned that LRKO mice might also have altered motivation to eat. Motivated feeding is influenced by two factors: how much the food is preferred (or "liked") and how much the food is "wanted" (40) . We first investigated whether food preference is altered in LRKO mice via a two-bottle sucrose preference test. Control and LRKO mice did not exhibit any differences in total liquid intake [ Increases in circulating ghrelin promote feeding, and this response is mediated, in part, via OX neurons (18, 22) . Because ghrelin-mediated activation of OX neurons is impaired in LRKO mice, we investigated whether this altered their feeding. Both control and LRKO mice increase chow intake in response to ghrelin treatment [ Fig. 5(E) , control = 0.48 6 0.15 g vs LRKO = 0.69 6 0.15 g, P = 0.557], indicating that adaptive feeding responses to ghrelin remain intact. Ghrelin treatment also increases 
Loss of action via Nts
LepRb neurons disrupts adaptive "wanting" of palatable food
Mesolimbic dopamine signaling can modify how much foods are "wanted" and thereby modify food intake. Because Nts LepRb neurons and their OX projection targets both engage the mesolimbic dopamine system (12, 22) , we investigated whether loss of action via these circuits impaired food wanting. We therefore assessed control and LRKO mice for their willingness to work for sucrose pellets in a PR operant task in which the breakpoint indicates the animal's relative level of reward "wanting." At baseline, the breakpoint of control and LRKO animals is similar, indicating that they similarly want, and will work for, palatable food [ Fig. 6(A) : control = 44.55 6 8.08 vs LRKO = 33.00 6 3.34, P = 0.157]. Leptin however, decreases operant responding for rewards (41), which might be mediated, in part, via Nts LepRb neurons. To examine this hypothesis, we treated control and LRKO mice with vehicle and leptin during PR testing. As expected, control mice decrease their PR breakpoint in response to leptin, indicating suppressed sucrose wanting, but LRKO mice do not [ Fig. 6(B) ,: control = 210.18 6 4.15 vs LRKO = 0.40 6 1.67, P = 0.015]. Ghrelin treatment increases PR breakpoint in control mice, consistent with previous reports (18) , but this increased wanting is blunted in ghrelin-treated LRKO mice and ghrelin from modifying the incentive salience of palatable foods, and thus prevents appropriate hormone-coordinated feeding.
Expression of LHA signaling peptides is altered after disruption of the Nts LepRb circuit Our previous and current data confirm that loss of action via Nts LepRb neurons prevents LHA neurons from being appropriately activated by leptin or ghrelin. Loss of neuronal activation could therefore impair adaptive response via preventing release of LHA signaling peptides that regulate postsynaptic target neurons, such as OX and mesolimbic dopamine neurons. To investigate this possibility, we isolated RNA from the LHA of control and LRKO mice and assessed expression of neuropeptides and hormone receptors that are specifically expressed in Nts LepRb neurons and OX neurons. Indeed, the loss of Nts LepRb neuronal action in LRKO mice coincides with diminished expression of Nts [ Fig. 7(B) : control = 1.05 6 0.13 fold, n = 8 vs LRKO = 0.62 6 0.07, n = 7, P = 0.012], suggesting that Nts LepRb neurons are no longer making sufficient Nts to mediate downstream signaling. Intriguingly, although at least some Nts LepRb neurons also coexpress the neuropeptide galanin (Gal), LRKO mice retain normal Gal expression. LepRb expression, however, is upregulated in LRKO mice, which likely reflects a compensatory effort to enhance leptin action via the population of non-Nts-expressing LepRb neurons [ Fig. 3(B) ]. Because Nts LepRb neurons project to and inhibit OX neurons, we hypothesized that expression of energy balance neuropeptides and receptors might be disrupted Figure 6 . Loss of action via Nts LepRb neurons disrupts adaptive reward wanting. Adult male control and LRKO mice were tested via a PR paradigm for their willingness to work for sucrose rewards (9 to 37 weeks old; control, n = 11; LRKO, n = 15). The PR breakpoint represents how much the sucrose reward is wanted. (A) Control and LRKO mice have similar baseline PR breakpoints at baseline. (B) Leptin treatment adaptively decreases the PR breakpoint in control mice, but not in LRKO mice, which are unable to respond to leptin via Nts LepRb neurons. (C) Ghrelin treatment adaptively increases the PR breakpoint in control mice, but not in LRKO mice. Graphed data represent average value 6 SEM. *P , 0.05 by Student t test.
in OX neurons of LRKO mice. OX expression remains similar between control and LRKO mice, consistent with previous findings (12) . There is a slight increase, however, in Dlk1, which is expressed in OX neurons and can be released to modify neuronal signaling (42, 43) . GHSR expression is also similar in control and LRKO mice, suggesting that the loss of ghrelin response in LRKO mice is not due to lacking the ability to bind ghrelin directly, but likely from disruption of other signaling mechanisms.
Nts LepRb neurons also project to the VTA, where released Nts activates neurotensin receptor-1 (NtsR1) expressing dopamine neurons and induces dopamine release into the NAc (12, 44) . Despite the loss of action via Nts LepRb neurons in LRKO mice, however, they do not exhibit any differences in VTA expression of tyrosine hydroxylase, the rate-limiting marker of dopamine synthesis), the dopamine active transporter, or NtsR1. These data suggest that loss of action via Nts LepRb neurons does not impair the functionality of VTA dopamine neurons and their ability to respond to Nts, per se. Instead, it is possible that the loss of leptin and ghrelin-mediated activation of LHA neurons results in diminished activation of VTA dopamine neurons and therefore reduces dopamine release to the NAc, which regulates motivated behaviors.
Loss of action via the Nts LepRb circuit disrupts the mesolimbic dopamine system LRKO mice exhibit blunted motivated feeding and locomotor responses to leptin and ghrelin; thus, we reasoned that these mice have diminished activation of the mesolimbic dopamine system. This could be solely due to diminished activation of the Nts LepRb and OX neurons (Figs. 2 and 3 ) that project to the VTA to activate dopamine neurons and promote dopamine release into the NAc. Another possibility is that the developmental deletion of LepRb in LRKO mice causes them to develop fewer neuronal projections to the VTA with which to modify dopamine signaling. To investigate this possibility, we visualized the projections of LHA Nts neurons by injecting Nts
Cre and LRKO mice in the LHA with Ad-Syn-mCherry, which causes cre-dependent expression of the synaptophysin-mCherry fusion protein in Nts-expressing neurons. Importantly, Syn-mCherry is expressed within cell bodies and localizes to axon terminals, thereby enabling detection of projections throughout the brain (23) . Injection of Ad-Syn-mCherry identifies similar numbers of cell bodies and projections within the LHA of control and LRKO mice [ Fig. 8 (A) and 8(D)], suggesting that there is no developmental defect in the number of Nts neurons or their local projections to OX neurons. By contrast, we observed that LRKO animals had fewer projections to the VTA than control mice [ Fig. 8(B), 3(C), 3(E), and 3(F) ]. These data indicate that 
deletion of LepRb from Nts
LepRb neurons diminishes the development of projections to the VTA, and thus presumably reduces the activation of VTA dopamine neurons and dopamine release to the NAc. If this were true, we anticipated that leptin-and ghrelin-mediated activation of the NAc would be decreased in LRKO mice compared with controls. To investigate this, we examined cFos in the NAc shell (NAcSh) and NAc core (NAcC), where dopamine release modifies motivated feeding and locomotion. As a first step, we treated control and LRKO mice with amphetamine, which promotes dopamine release and induces cFos, to verify that LRKO mice can exhibit dopamine-mediated activation of the NAc. Indeed, amphetamine increases cFos in both control and LRKO mice, though it is reduced in the latter [ Fig. 8(G) and 8(K) ]. These data are consistent with the reduced amphetaminemediated locomotor activity of LRKO mice compared with controls, suggesting that they have reduced capacity to adapt to signals that should increase mesolimbic dopamine signaling (12) . Next, we queried the activation of the mesolimbic dopamine system in response to vehicle, leptin, or ghrelin to determine whether the blunted adaptive response to hormones corresponds with diminished NAc activation. Control and LRKO mice have similarly low levels of striatal cFos after vehicle treatment [ Fig. 8 . In sum, these data confirm that loss of action via the Nts LepRb circuit disrupts leptinand ghrelin-mediated activation of mesolimbic dopamine signaling and thus can blunt the adaptive motivated behaviors regulated by these hormones.
Discussion
Here we define neural mechanisms by which the LHA coordinates leptin-and ghrelin-mediated adaptations in energy balance. Leptin specifically activates a subset of LHA Nts neurons that coexpress LepRb, the Nts LepRb neurons, to mediate weight loss behaviors. By contrast, ghrelin acts upon OX neurons to promote feeding.
Because Nts
LepRb neurons project to and inhibit OX neurons, they can indirectly modify ghrelin-mediated regulation of OX neurons. Loss of action via Nts LepRb neurons thus disrupts leptin-and ghrelin-mediated adaptive responses, discoordinating appropriate ingestive and locomotor behavior that leads to weight gain. Collectively, these data reveal an important role for Nts
LepRb neurons in mediating adaptive energy balance and normal body weight.
Our findings establish Nts neurons as a major neuronal population within the LHA that are vital for mediating energy balance. Previous physiological study of LHA Nts neurons was impeded by the inability to immunohistochemically detect them, as this required function-impairing colchicine treatment. Similar limitations deterred understanding of LHA populations containing Gal, GABA, or glutamate, but the recent development of cre-inducible mouse models enabled determination of their roles in energy balance (14, 45, 46) . We thus used a knockin cre-inducible mouse model to identify Nts neurons within the LHA and found that Nts neurons are codistributed among, but distinct from, OX and MCH neurons. Our findings differ from a report that all OX neurons contain Nts (47), which was determined with a commercial antibody that is no longer available. However, our data agree with reports that Nts is required for leptin-mediated inhibition of OX neurons, suggesting that Nts is released from LepRb neurons and is not in fact coexpressed within OX neurons (19) . Furthermore, because Nts is an anorectic neuropeptide (48, 49) , it is unlikely that it would be coexpressed within orexigenic OX neurons. Indeed, Nts in the LHA has been linked to suppressing feeding in response to dehydration, inflammation, and leptin (11, 12, 50) . Intriguingly, only 15% of LHA Nts neurons coexpress LepRb and are activated by leptin (Nts LepRb neurons). Thus, there are at least two subpopulations of LHA Nts neurons: the leptin-responsive Nts LepRb neurons and other non-LepRbexpressing Nts neurons with yet-to-be determined physiological roles. LHA Nts subpopulations may differ in neuropeptide or classical neurotransmitter content (28, 44, 51) , though at least the Nts LepRb neurons are GABAergic (12) . Going forward, it will be important to distinguish LHA Nts populations at the molecular and functional levels to determine their contributions to energy balance. Our data demonstrate that leptin and ghrelin engage separate, but interconnected, LHA circuits to exert adaptive energy balance. Leptin directly activates Nts LepRb neurons, but not OX neurons, because they lack LepRb (21) . Leptin regulates OX neurons indirectly however because Nts LepRb neurons synapse upon and inhibit OX neurons (24) . Nts
LepRb neurons also project to the VTA, where Nts activates dopamine neurons to induce dopamine release into the NAc (12, 44) . Therefore, leptin-regulated Nts LepRb neurons modify energy balance through two separate neuronal circuits: 1) via inhibiting orexigenic OX neurons and 2) via Nts-mediated activation of mesolimbic dopamine neurons. Although the specific contributions of these pathways have yet to be understood, leptin action via these Nts LepRb projections is required to limit feeding, promote physical activity, and hence maintain normal body weight. By contrast, ghrelin increases the proportion of activated OX neurons, but does not activate Nts neurons or LepRb neurons (17, 19) . Collectively, these data suggest that anorectic leptin directly activates LepRb-expressing neurons, whereas ghrelin can activate GHSR-expressing OX neurons, in agreement with electrophysiological studies (9, 19) . It remains unclear, however, whether all OX neurons express GHSR and can be directly activated by ghrelin. Indeed, we observed that ghrelin increases activation of some, but not all OX neurons, suggesting that there may be at least some non-GHSR-expressing OX neurons with unique functions. OX neurons can be distinguished into glucose-excited and glucose-inhibited populations; the latter population is more likely to be activated during energy depletion, when circulating ghrelin is high (52) . Our current work also does not exclude the possibility that ghrelin may also activate GHSR-expressing neurons outside of the LHA that project to and activate OX neurons. In any case, ghrelin can either directly or indirectly promote activation of OX neurons, but does not activate the separate Nts LepRb neurons. In the future, it will be important to define the precise subpopulations of LepRb and OX neurons regulated by leptin and ghrelin to fully understand how they dynamically modify adaptive energy balance. Nts LepRb neurons are required for normal energy balance, and loss of action via Nts LepRb neurons in LRKO mice results in hypolocomotion and increased body weight. Intriguingly, LRKO mice exhibit diminished physical activity but do not commensurately reduce food intake, thereby promoting weight gain. Reduced movement may result from disruption of the Nts LepRb → OX and/or Nts LepRb → VTA circuits because both OX and dopamine signaling promote locomotor activity (37, 53) . Indeed, leptin modifies dopamine -mediated running reward (33) and Nts activates VTA dopamine neurons to promote locomotor activity (54 
